Outsourced Drug Discovery Market is Up 17% Per Our Eighth Edition Study of the CRO Market

Outsourced Drug Discovery Market is Up 17%  Per Our Eighth Edition Study of the CRO Market

Increased demand for pharmaceutical "blockbusters," or even middle-of-the-road revenue earners, is fueling the need for outsourcing. Patent expiration and increased demand for R&D, when many firms have laid off workers in R&D, adds up to business for CROs. A trend we've been noticing since 2002. Current status in our most recent report.

  • by bcarlson@marketresearch.com
  • July 25 2014
  • drug cost


Expensive Drugs: Only At First Glance

Expensive Drugs: Only At First Glance

We concur with a recent article by Peter J. Pitts, a former FDA associate commissioner ("Why ‘Pricey’ Drugs Save Money - and Lives," in the New York Post. In that article Pitts argues against expensive new drugs as the culprit to rising US health-care costs. Pitts explains that pricey drugs can save money when used correctly. Our Top 25 pharma company pipeline report report available on Kalorama’s website, demonstrates the type of therapies that top companies are working on currently.

He consi...